KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody

December 10, 2013

Source: Humanigen, Inc.

Released December 10, 2013

©2019 Humanigen, Inc.  All rights reserved